March 19, 2025 • The United Nations has long been in the spotlight over allegations of child rape and other sexual abuses by its peacekeepers, especially by those based in Congo and the Central ...
Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last ...
ROTTERDAM, the Netherlands and SAN DIEGO, Feb. 28, 2025 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for ...
In the Asia Pacific region, Sarclisa combination regimens were also recently approved by the National Medical Products Administration in China, specifically Sarclisa-VRd in NDMM patients who are ...
Washington Post owner Jeff Bezos has announced that the newspaper's opinion section will focus on supporting “personal liberties and free markets", and pieces opposing those views will not be ...
The government has published a green paper on reforms to the construction products regime, as part of its response to the Grenfell Tower Inquiry phase two report. The government has published a green ...
The Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment of adult patients with newly ...
CAMAS — Camas city officials have asked the state Department of Ecology to require cleanup at the Georgia-Pacific paper mill site extensive enough to make it safe for housing and other uses ...
Sanofi’s Sarclisa has received approval in more than 50 nations and regions. Credit: LCV/Shutterstock. Sanofi’s Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and ...
J.D. Irving Ltd. bought its east Saint John paper mill in 1981. (Roger Cosman / CBC News) "The timing of this was not expected," said Murray. "Obviously, this demonstrates the importance of ...
Sanofi's Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and Welfare for use in conjunction with bortezomib, lenalidomide and dexamethasone (VRd) to treat adults with ...